Arentz Law Group Reports on FDA Essure birth control safety update
FDA announces public meeting to discuss risks and benefits of Essure birth control
By: Arentz Law Group
This afternoon the U.S. Food and Drug Administration (FDA) added a page to their website informing the public of increased risks associated with the Essure Permanent Birth Control Implant. The new page acknowledges the 5,093 adverse events that have been reported to the agency about Essure and provides new information about serious risks associated with the device including: pelvic pain, migration of Essure coils, perforation of the uterus or fallopian tubes, and rash and itching. The page also advises physicians to warn patients about complications that have resulted in women with nickel allergies who have received the Essure Birth Control Implant.
One section of the webpage recognizes reports of miscarriage and ectopic pregnancy following the non-surgical sterilization procedure, stating, "The FDA will continue to monitor the safety of Essure to make certain that its benefits of providing women with a non-incisional sterilization choice continue to outweigh its risks," and "While scientific evidence shows that Essure is a highly effective means of sterilization when health care providers and patients follow the appropriate instructions for use, no form of birth control is 100% effective."
The FDA announced today that there will be a public meeting of their Obstetrics and Gynecology Devices Panel later this year on September 24, 2015, to discuss the safety and efficacy of the device.
The defective device attorneys of Arentz Law Group continue to provide free legal consultations to women who have suffered due to adverse side effects of Essure. Women interested in consulting with an attorney or learning more about their legal options are encouraged to call 1-800-305-6000 or visit http://arentzlaw.com/
Additional information about Essure, as well as breaking news and updates can be found on the Arentz law Group official Essure Information Facebook Page.
Page Updated Last on: Jun 24, 2015